Investor Presentaiton

Therapy Selection has multiple growth drivers well beyond 2023 INVESTOR 20 DAY 23 Portfolio ASP increases GUARDANT 360 CDX GUARDANT 360 TissueNext GUARDANT 360 Response Future Guardant360 CDx approvals TissueNext & Response attachment GUARDANT - $ Market expansion GUARDANTINFINITY Infinity offering to biopharma partners International expansion, e.g., Japan, UK, China 145

View entire presentation